- Previous Close
67.60 - Open
65.00 - Bid 64.10 x --
- Ask --
- Day's Range
65.00 - 65.00 - 52 Week Range
45.50 - 90.00 - Volume
7 - Avg. Volume
111 - Market Cap (intraday)
883.708M - Beta (5Y Monthly) 0.95
- PE Ratio (TTM)
209.68 - EPS (TTM)
0.31 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. It serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. The company was incorporated in 1997 and is headquartered in Basel, Switzerland.
www.medartis.comRecent News: MEDZ.XC
View MorePerformance Overview: MEDZ.XC
Trailing total returns as of 1/15/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MEDZ.XC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MEDZ.XC
View MoreValuation Measures
Market Cap
910.90M
Enterprise Value
904.76M
Trailing P/E
218.06
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.97
Price/Book (mrq)
3.37
Enterprise Value/Revenue
4.11
Enterprise Value/EBITDA
31.06
Financial Highlights
Profitability and Income Statement
Profit Margin
1.83%
Return on Assets (ttm)
1.84%
Return on Equity (ttm)
1.50%
Revenue (ttm)
220.28M
Net Income Avi to Common (ttm)
4.03M
Diluted EPS (ttm)
0.31
Balance Sheet and Cash Flow
Total Cash (mrq)
127.09M
Total Debt/Equity (mrq)
44.37%
Levered Free Cash Flow (ttm)
20.47M